Drugplain

BUTALBITAL, ASPIRIN, AND CAFFEINE 325 mg/1

BUTALBITAL, ASPIRIN, AND CAFFEINE · CAPSULE · Westminster Pharmaceuticals, LLC

No Recall History
Plain English

This is a prescription capsule containing butalbital (a barbiturate), aspirin (a nonsteroidal anti-inflammatory drug), and caffeine, taken by mouth to treat tension headaches and migraines. The combination works by reducing pain and inflammation while the caffeine enhances the pain-relieving effects of the other ingredients.

Key Facts

Brand Name
BUTALBITAL, ASPIRIN, AND CAFFEINE
Generic Name
BUTALBITAL, ASPIRIN, AND CAFFEINE
NDC Code (Product)
69367-416
Manufacturer
Westminster Pharmaceuticals, LLC
Strength
325 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
DEA Schedule
Schedule III (Controlled)
Application #
ANDA078149
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
10/24/2025

Recall History

No Recall History

Frequently Asked Questions

What is BUTALBITAL, ASPIRIN, AND CAFFEINE used for?

This is a prescription capsule containing butalbital (a barbiturate), aspirin (a nonsteroidal anti-inflammatory drug), and caffeine, taken by mouth to treat tension headaches and migraines. The combination works by reducing pain and inflammation while the caffeine enhances the pain-relieving effects of the other ingredients.

Is BUTALBITAL, ASPIRIN, AND CAFFEINE a controlled substance?

Yes, BUTALBITAL, ASPIRIN, AND CAFFEINE is classified as CIII under the DEA Controlled Substances Act.

What is the generic name for BUTALBITAL, ASPIRIN, AND CAFFEINE?

The generic name for BUTALBITAL, ASPIRIN, AND CAFFEINE is BUTALBITAL, ASPIRIN, AND CAFFEINE. There are 4 other brand versions of BUTALBITAL, ASPIRIN, AND CAFFEINE.

What is the NDC code for BUTALBITAL, ASPIRIN, AND CAFFEINE 325 mg/1?

The NDC (National Drug Code) for BUTALBITAL, ASPIRIN, AND CAFFEINE 325 mg/1 is 69367-416, listed by Westminster Pharmaceuticals, LLC.

Product NDC

69367-416

Package NDC

69367-416-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)